Aldeyra Therapeutics completes enrollment in part 1 of phase 3 study of eye disorder drug
January 04 2022 - 10:50AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2024 to May 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From May 2023 to May 2024